Ludger Roedder
President chez Adare Pharmaceuticals SAS
Profil
Ludger Roedder is currently a member of the Council for Responsible Nutrition, a member of the American Feed Industry Association, and the President of Adare Pharmaceuticals SAS.
He was previously the Chief Business Officer at BRAIN Biotech AG.
Mr. Roedder holds a Master's in Business Administration from Fairleigh Dickinson University.
Postes actifs de Ludger Roedder
| Sociétés | Poste | Début |
|---|---|---|
| American Feed Industry Association | Corporate Officer/Principal | - |
| Council for Responsible Nutrition | Corporate Officer/Principal | - |
Adare Pharmaceuticals SAS
 Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | President | 03/12/2021 |
Anciens postes connus de Ludger Roedder
| Sociétés | Poste | Fin |
|---|---|---|
| BRAIN BIOTECH AG | Corporate Officer/Principal | 07/07/2020 |
Formation de Ludger Roedder
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRAIN BIOTECH AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
| American Feed Industry Association | |
| Council for Responsible Nutrition | |
Adare Pharmaceuticals SAS
Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | Health Technology |
